[{"Assets_0_Q3_USD":334343000.0,"CommonStockSharesOutstanding_0_Q3_shares":156808126.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-16855000.0,"NetIncomeLoss_1_Q3_USD":20648000.0,"NetIncomeLoss_3_Q3_USD":-26353000.0,"StockholdersEquity_0_Q3_USD":-153047000.0,"Ticker":"IRWD","CIK":"1446847","name":"IRONWOOD PHARMACEUTICALS INC","OfficialName":"Ironwood Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1913848067.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191031"}]